Vir Biotechnology, Inc.
VIR
$4.38
$0.020.46%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -59.96% | -75.50% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -59.96% | -75.50% | |||
| Cost of Revenue | -17.09% | 32.47% | |||
| Gross Profit | 15.95% | -49.95% | |||
| SG&A Expenses | -6.94% | -10.33% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -15.37% | 22.57% | |||
| Operating Income | 14.39% | -34.34% | |||
| Income Before Tax | 8.40% | -15.55% | |||
| Income Tax Expenses | 962.50% | 118.60% | |||
| Earnings from Continuing Operations | 8.27% | -15.66% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 8.27% | -15.66% | |||
| EBIT | 14.39% | -34.34% | |||
| EBITDA | 14.73% | -35.35% | |||
| EPS Basic | 8.92% | -15.09% | |||
| Normalized Basic EPS | 15.44% | -40.52% | |||
| EPS Diluted | 8.92% | -15.09% | |||
| Normalized Diluted EPS | 15.44% | -40.52% | |||
| Average Basic Shares Outstanding | 0.71% | 0.48% | |||
| Average Diluted Shares Outstanding | 0.71% | 0.48% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||